| Qualified item | Emergency physician critical care, first 30–74 minutes (CPT 99291) |
| Dispute structure | Single-item Federal IDR dispute |
| Clinical presentation | Septic shock with acute hypoxemic respiratory failure, vasopressor initiation, and emergent source-control coordination |
| Initial payment | $690 · fictional client-supplied field |
| Qualifying Payment Amount | $720 · fictional client-supplied disclosure |
| Initiating party offer | $2,100 · selected and approved by client |
| Non-initiating party offer | $720 · shown separately even where numerically identical to QPA |
| Clinovian scope | Clinical evidence synthesis, record mapping, and narrative QA only |
| Clinical fact | Record support | Why it matters |
|---|---|---|
| Shock at presentation | BP 78/46 after initial fluid bolus; lactate 5.2 mmol/L; mottled extremities | Establishes immediate life-threatening instability and high-risk medical decision-making. |
| Vasopressor management | Norepinephrine initiated and titrated through central access with continuous reassessment | Supports active critical-care management rather than routine emergency evaluation. |
| Respiratory failure | SpO₂ 84% on room air; escalating oxygen support; arterial blood gas and airway-readiness documentation | Demonstrates concurrent organ dysfunction and resource intensity. |
| Source-control coordination | Urgent surgical consultation, broad-spectrum antibiotics, serial reassessment, transfer to operating room | Shows time-sensitive multidisciplinary management with high risk of deterioration. |
| Critical-care time | 58 minutes of non-duplicative physician critical-care time documented | Supports the clinical intensity of the disputed service, subject to client coding validation. |
1 — Training, experience, quality and outcomes. The treating physician’s emergency-medicine certification, critical-care experience, and client-supplied quality data may be relevant if verified and connected to the disputed service. Generic credential statements are excluded.
2 — Market share of the parties. Market-share evidence is outside the medical record. Clinovian flags it for client or counsel validation and does not infer it from the clinical file.
3 — Patient acuity or complexity of furnishing the service. Strongly supported. Shock, respiratory failure, vasopressor titration, serial reassessment, and emergent source-control coordination materially distinguish the encounter from a routine high-acuity ED visit.
4 — Teaching status, case mix and scope of services. Potentially relevant if the client verifies the facility’s status and explains how its capabilities were material to this encounter. The dossier does not assume that facility status alone changes value.
5 — Good-faith contracting efforts and prior contracted rates. Client-supplied contracting evidence may be included where applicable. Clinovian does not convert contracting history into a clinical conclusion.
The QPA is not labeled as the payer’s offer, and the initial payment is not treated as interchangeable with either figure. The dossier does not claim that the QPA is invalid or incapable of reflecting any complexity.
The case-specific severity, risk, and resource intensity documented here may not be fully captured by the QPA or initial payment. The client may use this evidence, together with other credible permissible information, when supporting its independently selected offer.
Clinical conclusion for client review. The record supports a materially complex critical-care encounter involving hemodynamic shock, respiratory failure, vasopressor management, serial reassessment, and urgent source-control coordination. Those case-specific facts provide a credible clinical basis for distinguishing the service from a routine emergency encounter. The client retains responsibility for deciding how that evidence relates to its offer and for all procedural and legal submissions.